2001Unpublished venueRequires access

Construction of pcDNA3.1(+)GDNF vector and its expression in eukaryotic cells

Yong Zhao

Open publisher page 0 citations

Abstract

Objective To construct pcDNA3.1(+)GDNF recombinant eukaryotic expression plasmid and to investigate its expression in eukaryotic cells.Methods The coding sequence of GDNF was amplified from rat astrocytes by reverse transcription PCR (RT PCR) and was cloned into pcDNA3.1(+) eukaryotic expression vector.The recombinant pcDNA3.1(+)GDNF plasmid was then transfected into eukaryotic cells mediated by Fu Gene 6.Analysis by restriction enzyme digestion and DNA sequencing were carried out to demonstrate the sequence of the plasmid.GDNF protein and its activity were then determined using pcDNA3.1(+)GDNF plasmid transfected eukaryotic cells.Results The results of restriction enzyme and DNA sequencing revealed that GDNF cloning was successful.The recombinant plasmid could express active GDNF protein in the eukaryotic cells.Conclusions Further study on the role of both GDNF and gene therapy is helpful in the treatment Parkinson's disease.

About this research paper

What this paper is about

Objective To construct pcDNA3.1(+)GDNF recombinant eukaryotic expression plasmid and to investigate its expression in eukaryotic cells.Methods The coding sequence of GDNF was amplified from rat astrocytes by reverse transcription PCR (RT PCR) and was cloned into pcDNA3.1(+) eukaryotic expression vector.The recombinant pcDNA3.1(+)GDNF plasmid was then transfected into eukaryotic cells mediated by Fu Gene 6.Analysis by restriction enzyme digestion and DNA sequencing were carried out to demonstrate the sequence of the plasmid.GDNF protein and its activity were then determined using pcDNA3.1(+)GDNF plasmid transfected eukaryotic cells.Results The results of restriction enzyme and DNA sequencing revealed that GDNF cloning was successful.The recombinant plasmid could express active GDNF protein in the eukaryotic cells.Conclusions Further study on the role of both GDNF and gene therapy is helpful in the treatment Parkinson's disease.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To construct pcDNA3.1(+)GDNF recombinant eukaryotic expression plasmid and to investigate its expression in eukaryotic cells.Methods The coding sequence of GDNF was amplified from rat astrocytes by reverse transcription PCR (RT PCR) and was cloned into pcDNA3.1(+) eukaryotic expression vector.The recombinant pcDNA3.1(+)GDNF plasmid was then transfected into eukaryotic cells mediated by Fu Gene 6.Analysis by restriction enzyme digestion and DNA sequencing were carried out to demonstrate the sequence of the plasmid.GDNF protein and its activity were then determined using pcDNA3.1(+)GDNF plasmid transfected eukaryotic cells.Results The results of restriction enzyme and DNA sequencing revealed that GDNF cloning was successful.The recombinant plasmid could express active GDNF protein in the eukaryotic cells.Conclusions Further study on the role of both GDNF and gene therapy is helpful in the treatment Parkinson's disease.

Key concepts: Glial cell line-derived neurotrophic factor, Recombinant DNA, Plasmid, Transfection, Molecular biology, Biology, Gene, Coding region

Related papers

Back to paper searchBrowse research topicsOriginal source
Construction of pcDNA3.1(+)GDNF vector and its expression in eukaryotic cells — Research Paper | ScholarLens